Stock Analiz

Helus Pharma Inc. (HELP) stock forecast and price target

Price $8.87 · data as of November 13, 2026

12-month price target

Average target$40.61
Upside / downside+357.8%
Analysts10
ConsensusStrong buy
Low $14.85Average $40.61High $68.93

Gold marker: average target · white marker: today’s price ($8.87)

Analyst ratings

Strong buy 1Buy 10Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends March 31, 2027
$-4.10+30.6%$0
Next fiscal year
ends March 31, 2028
$-2.47+39.8%$14M
Next quarter
ends December 31, 2026
$-0.95+30.5%$0
Quarter after
ends March 31, 2027
$-0.98+18.4%$0

Consensus of the analysts covering Helus Pharma, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Helus Pharma stock price target?

The average 12-month target from 10 analysts is $40.61, 357.8% above the current price of $8.87 Targets range from $14.85 to $68.93.

Is Helus Pharma a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 10 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Helus Pharma expected to earn?

Analysts expect EPS of $-4.10 for the fiscal year ending March 31, 2027 and $-2.47 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.